22. Cervical cancer screening among female clients and related factors at a vaccination unit in Hanoi, 2018

Tran Thi Thuy Linh, Le Thi Thanh Xuan, Nguyen Van Thanh

Nội dung chính của bài viết

Tóm tắt

Cervical cancer is really a public health problem that should be prioritized for prevention, interventions and early screening, especially in developing countries. A cross-sectional study was conducted at a Hanoi Medical University vaccination unit in 2018 to identify the prevalence of and related factors with cervical cancer screening among female clients in Hanoi, Vietnam. We collected data using a structured questionnaire among 405 female clients. The results showed that the prevalence of study participants who had the decision on cervical cancer screening was 79.5%. Associated factors of cervical cancer screening among female clients were have had sex with 1 person (OR= 42.5; 95%CI= 5.6-311.2), 2 people (OR= 29.7; 95%CI= 3.84- 230) and 3 people (OR= 41.6; 95%CI= 4.68- 369.9). There is a statistically significant relationship between two variables [average monthly income (OR= 2.79, 95%CI= 1.19- 6.56), and sex status (OR=20.9, 95%CI= 2.52- 173.39) with the decision to screen for cervical cancer. Enhancing the proportion of cervical cancer screening by fostering knowledge and awareness about human papillomavirus, and cervical cancer and using health services assessment will be highly recommended in Vietnam.

Chi tiết bài viết

Tài liệu tham khảo

1. Kimmel SR. Practical implementation of HPV vaccines in clinical practice. J Fam Pract. Nov 2006; Suppl:18-22.
2. Tyler M, Tumban E, Chackerian B. Second-generation prophylactic HPV vaccines: successes and challenges. Expert Rev Vaccines. Feb 2014; 13(2): 247-55. doi:10.1586/14760584.2014.865523.
3. Ministry of Health. National Guidelines for Reproductive Health Services. 2018;
4. Oanh LTTHaLT. Epidemiological characteristics of HPV infection among women in two districts of Hanoi and Ho Chi Minh City in 2010, Epidemiology and cancer prevention program. Vietnam Journal of Oncology. 2010; (1): 138-144.
5. WHO. Global strategy to accelerate the elimination of cervical cancer as a public health problem. Accessed 05/04/2022, https://www.who.int/publications/i/item/9789240014107
6. WHO. Human Papillomavirus (HPV). Accessed 05/04/2022, https://www.who.int/teams/health-product-policy-and-standards/standards-and-specifications/vaccine-standardization/human-papillomavirus.
7. CDC. HPV Infection. Basic Information about HPV and Cancer. Accessed 05/04/2022, https://www.cdc.gov/cancer/hpv/basic_info/index.htm.
8. Ministry of Health. Pilot project on screening for early detection of cervical cancer and treatment in some provinces in the period of 2019 - 2025. 2019;
9. D. L. Screening for cervical cancer in resource-limited setting. Accessed 20/09/2022, https://www.uptodate.com/contents/screening-for-cervical-cancer-in-resource-limited-settings
10. Wado YD. Women’s autonomy and reproductive health-care-seeking behavior in Ethiopia. Women Health. Aug 2018; 58(7): 729-743. doi:10.1080/03630242.2017.1353573.
11. Long L, Han Y, Tong L, Chen Z. Association between condom use and perspectives on contraceptive responsibility in different sexual relationships among sexually active college students in China: A cross-sectional study. Medicine (Baltimore). Jan 2019; 98(1): e13879. doi:10.1097/md.0000000000013879.
12. Choudhry S, Ramachandran VG, Das S, Bhattacharya SN, Mogha NS. Characterization of patients with multiple sexually transmitted infections: A hospital-based survey. Indian J Sex Transm Dis AIDS. Jul 2010; 31(2): 87-91. doi:10.4103/0253-7184.74978.
13. Sawaya GF, McConnell KJ, Kulasingam SL, et al. Risk of Cervical Cancer Associated with Extending the Interval between Cervical-Cancer Screenings. New England Journal of Medicine. 2003; 349(16): 1501-1509. doi:10.1056/NEJMoa035419
14. Ministry of Health. National action plan on prevention and control of cervical cancer 2016-2025. 2016;